NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
Recruiting
4,000 enrolled
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Recruiting
6,035 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Recruiting
1,310 enrolled
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
275 enrolled
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Recruiting
800 enrolled
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Recruiting
10,000 enrolled
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
Recruiting
1,000 enrolled
Retinoblastoma Biomarker Study
Completed
2,136 enrolled
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Completed
55 enrolled
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
Terminated
241 enrolled
Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C
Completed
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
Unknown
60 enrolled
Pharmacokinetics of Dactinomycin in Young Patients With Cancer
Unknown
50 enrolled
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer
Unknown
20 enrolled
Study of Hair Samples From Patients With Cancer
Completed
190 enrolled
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Unknown
270 enrolled